The US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to ADVAITE’s RapCov Rapid COVID-19 Test. The biotech company is among the handful of manufacturers to be granted EUA for a point-of-care serology test.
Biomerica, a global biomedical company that manufactures diagnostic products, has received CE mark certification for its new Covid-19 Rapid Antigen Test that helps in detecting the SARS-Cov-2 virus. The company has already received its first orders and plans to ship the tests in the weeks ahead and will now market its product across the Europe and outside the US.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Abbott has fulfilled the US government’s purchase order of 150 million BinaxNOW Covid-19 Ag tests. These tests were distributed across the Department of Health and Human Services (HHS) to states, territories, nursing homes, historically black colleges and universities (HBCUs), assisted living facilities, home health and hospice agencies, and the Indian Health Service. The company will supply 30 million additional tests through March under a new government order.
